Clinical Trial Update: Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars [Phase 1]

View source ↗

Summary

Phase 1 trial sponsored by GlaxoSmithKline evaluating fractional collagen synthesis in keloid scar tissue and identifying biomarkers; the fibrosis-related study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis
• Keloid Scar

Drugs mentioned

• Not disclosed

Snippet

Sponsor: GlaxoSmithKline | Conditions: Fibrosis | Phase 1 | Status: TERMINATED